Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study

✍ Scribed by Strain, W David; Lukashevich, Valentina; Kothny, Wolfgang; Hoellinger, Marie-José; Paldánius, Päivi Maria

• Book ID: 122677088
• Publisher: The Lancet
• Year: 2013
• Tongue: English
• Weight: 302 KB
• Volume: 382
• Category: Article
• ISSN: 0140-6736
• DOI: 10.1016/S0140-6736(13)60995-2